I agree that this site is using cookies. You can find further informations here.
X
Holtan, Shernan G
295  results:
Search for persons X
?
1

Treatment-Responsive Acute Graft-versus-Host Disease after ..:

Herzog, Shannon ; Shanley, Ryan ; Holtan, Shernan G....
Transplantation and Cellular Therapy.  30 (2024)  7 - p. 688.e1-688.e9 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Long- and short-term effects of fecal microbiota transplant..:

Rashidi, Armin ; Ebadi, Maryam ; Rehman, Tauseef Ur...
Gut Microbes.  16 (2024)  1 - p. , 2024
Link: https://doi.org/10.1080/..
 
?
3

Treatment-Sensitive and Treatment-Dependent Chronic Graft-v..:

El Jurdi, Najla ; Herzog, Shannon ; Shanley, Ryan...
Transplantation and Cellular Therapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

Allogeneic hematopoietic cell transplant for bone marrow fa..:

Dimitrov, Marketa ; Merkle, Svatava ; Cao, Qing...
Transplantation and Cellular Therapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
5

Multi-omics Analysis of a Fecal Microbiota Transplantation ..:

Rashidi, Armin ; Ebadi, Maryam ; Rehman, Tauseef U....
Cancer Research Communications.  4 (2024)  6 - p. 1454-1466 , 2024
Link: https://doi.org/10.1158/..
 
?
6

Health-Related Quality of Life Outcomes in Older Hematopoie..:

Hong, Sanghee ; Zhao, Jing ; Wang, Shu...
Transplantation and Cellular Therapy.  29 (2023)  3 - p. 202.e1-202.e8 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Bringing Patient and Caregivers Voices to the Clinical Tria..:

Vasu, Sumithira ; Holtan, Shernan G. ; Shimamura, Akiko...
Transplantation and Cellular Therapy.  29 (2023)  1 - p. 5-9 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Chronic GVHD after steroid-sensitive, -dependent, and -refr..:

Herzog, Shannon ; Weisdorf, Daniel J. ; Shanley, Ryan...
Blood Advances.  7 (2023)  14 - p. 3644-3650 , 2023
Link: https://doi.org/10.1182/..
 
?
9

Amphiregulin as monitoring biomarker for life-threatening a..:

Holtan, Shernan G. ; El Jurdi, Najla ; Rashidi, Armin...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
10

The best GVHD prophylaxis: Or at least progress towards fin..:

Weisdorf, Daniel ; El Jurdi, Najla ; Holtan, Shernan G.
Best Practice & Research Clinical Haematology.  36 (2023)  4 - p. 101520 , 2023
Link: https://doi.org/10.1016/..
 
?
11

A prospective phase 2 clinical trial of a C5a complement in..:

Mehta, Rohtesh S. ; Ali, Haris ; Dai, Yang...
Bone Marrow Transplantation.  58 (2023)  9 - p. 991-999 , 2023
Link: https://doi.org/10.1038/..
 
?
12

Phase II Study of Myeloablative 7-8/8-Matched Allotransplan..:

Jurdi, Najla El ; Hoover, Alex ; O'Leary, Daniel...
Transplantation and Cellular Therapy.  29 (2023)  9 - p. 576.e1-576.e5 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Human Effectors of Acute and Chronic GVHD Overexpress CD83 ..:

Holtan, Shernan G. ; Savid-Frontera, Constanza ; Walton, Kelly...
Clinical Cancer Research.  29 (2023)  6 - p. 1114-1124 , 2023
Link: https://doi.org/10.1158/..
 
?
14

Patient-Reported Outcomes in Long-Term Survivors of Autolog..:

Chakraborty, Rajshekhar ; Yi, Jean ; Rybicki, Lisa...
Transplantation and Cellular Therapy.  29 (2023)  6 - p. 388.e1-388.e6 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Phase II, Open-Label Clinical Trial of Urinary-Derived Huma..:

Holtan, Shernan G. ; Hoeschen, Andrea ; Cao, Qing...
Transplantation and Cellular Therapy.  29 (2023)  8 - p. 509.e1-509.e8 , 2023
Link: https://doi.org/10.1016/..
 
1-15